|
1
|
Godar M, Blanchetot C, de Haard H,
Lambrecht BN and Brusselle G: Personalized medicine with biologics
for severe type 2 asthma: Current status and future prospects.
MAbs. 10:34–45. 2018. View Article : Google Scholar :
|
|
2
|
Dominguez-Ortega J, Phillips-Anglés E,
Barranco P and Quirce S: Cost-effectiveness of asthma therapy: A
comprehensive review. J Asthma. 52:529–537. 2015. View Article : Google Scholar
|
|
3
|
Eder W, Ege MJ and von Mutius E: The
asthma epidemic. N Engl J Med. 355:2226–2235. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wenzel SE: Asthma phenotypes: The
evolution from clinical to molecular approaches. Nat Med.
18:716–725. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Barnes CB and Ulrik CS: Asthma and
adherence to inhaled corticosteroids: Current status and future
perspectives. Respir Car. 60:455–468. 2015. View Article : Google Scholar
|
|
6
|
Conner JB and Buck PO: Improving asthma
management: The case for mandatory inclusion of dose counters on
all rescue bronchodilators. J Asthma. 50:658–663. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Szefler SJ: Advances in pediatric asthma
in 2012: Moving toward asthma prevention. J Allergy Clin Immunol.
131:36–46. 2013. View Article : Google Scholar
|
|
8
|
Petronella SA and Conboy-Ellis K: Asthma
epidemiology: Risk factors, case finding, and the role of asthma
coalitions. Nurs Clin North Am. 38:725–735. 2003. View Article : Google Scholar
|
|
9
|
Pflanz S, Timans JC, Cheung J, Rosales R,
Kanzler H, Gilbert J, Hibbert L, Churakova T, Travis M, Vaisberg E,
et al: IL-27, a heterodimeric cytokine composed of EBI3 and p28
protein, induces proliferation of naive CD4+ T cells.
Immunity. 16:779–790. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hunter CA: New IL-12-family members: IL-23
and IL-27, cytokines with divergent functions. Nat Rev Immunol.
5:521–531. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Meka RR, Venkatesha SH, Dudics S, Acharya
B and Moudgil KD: IL-27-induced modulation of autoimmunity and its
therapeutic potential. Autoimmun Rev. 14:1131–1141. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Owaki T, Asakawa M, Fukai F, Mizuguchi J
and Yoshimoto T: IL-27 induces Th1 differentiation via p38
MAPK/T-bet- and intercellular adhesion
Molecule-1/LFA-1/ERK1/2-dependent pathways. J Immunol.
177:7579–7587. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang RX, Yu CR, Mahdi RM and Egwuagu CE:
Novel IL27p28/IL12p40 cytokine suppressed experimental autoimmune
uveitis by inhibiting autoreactive Th1/Th17 cells and promoting
expansion of regulatory. T cells J Biol Chem. 287:36012–36021.
2012. View Article : Google Scholar
|
|
14
|
Artis D, Villarino A, Silverman M, He W,
Thornton EM, Mu S, Summer S, Covey TM, Huang E, Yoshida H, et al:
The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive
elements of type 2 immunity. J Immunol. 173:5626–5634. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wills-Karp M: Immunologic basis of
antigen-induced airway hyperresponsiveness. Annu Rev Immunol.
17:255–281. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Venkayya R, Lam M, Willkom M, Grünig G,
Corry DB and Erle DJ: The Th2 lymphocyte products IL-4 and IL-13
rapidly induce airway hyperresponsiveness through direct effects on
resident airway cells. Am J Respir Cell Mol Biol. 26:202–208. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yoshimoto T, Yoshimoto T, Yasuda K,
Mizuguchi J and Nakanishi K: IL-27 suppresses Th2 cell development
and Th2 cytokines production from polarized Th2 cells: A novel
therapeutic way for Th2-mediated allergic inflammation. J Immunol.
179:4415–4423. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xie M, Mustovich AT, Jiang Y, Trudeau JB,
Ray A, Ray P, Hu H, Holguin F, Freeman B and Wenzel SE: IL-27 and
type 2 immunity in asthmatic patients: Association with severity,
CXCL9, and signal transducer and activator of transcription
signaling. J Allergy Clin Immunol. 135:386–394. 2015. View Article : Google Scholar
|
|
19
|
Fujita H, Teng A, Nozawa R,
Takamoto-Matsui Y, Katagiri-Matsumura H, Ikezawa Z and Ishii Y:
Production of both IL-27 and IFN-gamma after the treatment with a
ligand for invariant NK T cells is responsible for the suppression
of Th2 response and allergic inflammation in a mouse experimental
asthma model. J Immunol. 183:254–260. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Miyazaki Y, Inoue H, Matsumura M,
Matsumoto K, Nakano T, Tsuda M, Hamano S, Yoshimura A and Yoshida
H: Exacerbation of experimental allergic asthma by augmented Th2
responses in WSX-1-deficient mice. J Immunol. 175:2401–2407. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jirmo AC, Daluege K, Happle C, Albrecht M,
Dittrich AM, Busse M, Habener A, Skuljec J and Hansen G: IL-27 is
essential for suppression of experimental allergic asthma by the
TLR7/8 agonist R848 (Resiquimod). J Immunol. 197:4219–4227. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Su X, Pan J, Bai F, Yuan H, Dong N, Li D,
Wang X and Chen Z: IL-27 attenuates airway inflammation in a mouse
asthma model via the STAT1 and GADD45γ/p38 MAPK pathways. J Transl
Med. 14:2832016. View Article : Google Scholar
|
|
23
|
Liu X, Li S, Jin J, Zhu T, Xu K, Liu C,
Zeng Y, Mao R, Wang X and Chen Z: Preventative tracheal
administration of interleukin-27 attenuates allergic asthma by
improving the lung Th1 microenvironment. J Cell Physiol.
234:6642–6653. 2019. View Article : Google Scholar
|
|
24
|
Villarino AV, Huang E and Hunter CA:
Understanding the pro- and anti-inflammatory properties of IL-27. J
Immunol. 173:715–720. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hirase T, Hara H, Miyazaki Y, Ide N,
Nishimoto-Hazuku A, Fujimoto H, Saris CJM, Yoshida H and Node K:
Interleukin 27 inhibits atherosclerosis via immunoregulation of
macrophages in mice. Am J Physiol Heart Circ Physiol.
305:H420–H429. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Department of Health and Human Services:
Guide for the care and use of laboratory animals. (NIH Pub no
85-23). Washington, DC: 1985
|
|
27
|
Reddy AT, Lakshmi SP and Reddy RC: Murine
model of allergen induced asthma. J Vis Exp. e37712012.PubMed/NCBI
|
|
28
|
Harikrishnan VS, Hansen AK, Abelson KS and
Sørensen DB: A comparison of various methods of blood sampling in
mice and rats: Effects on animal welfare. Lab Anim. 52:253–264.
2018. View Article : Google Scholar
|
|
29
|
Kirstein F, Nieuwenhuizen NE, Jayakumar J,
Horsnell WGC and Brombacher F: Role of IL-4 receptor alpha-positive
CD4(+) T cells in chronic airway hyperresponsiveness. J Allergy
Clin Immunol. 137:1852–1862e9. 2016. View Article : Google Scholar
|
|
30
|
Hoymann HG: Lung function measurements in
rodents in safety pharmacology studies. Front Pharmacol. 3:1562012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Overmyer KA, Thonusin C, Qi NR, Burant CF
and Evans CR: Impact of anesthesia and euthanasia on metabolomics
of mammalian tissues: Studies in a C57BL/6J mouse model. PLoS One.
10:e01172322015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Martin TR, Gerard NP, Galli SJ and Drazen
JM: Pulmonary responses to bronchoconstrictor agonists in the
mouse. J Appl Physiol. 64:2318–2323. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Leary S, Underwood W, Anthony R, Cartner
S, Corey D, Grandin T, Greenacre C, Gwaltney-Brant S, McCrackin MA,
Meyer R, et al: AVMA guidelines for the euthanasia of animals: 2013
edition. Available at: https://www.avma.org/KB/Policies/Documents/euthanasia.pdf.
2013
|
|
34
|
Cataldo DD, Tournoy KG, Vermaelen K,
Munaut C, Foidart JM, Louis R, Noël A and Pauwels RA: Matrix
metalloproteinase-9 deficiency impairs cellular infiltration and
bronchial hyperresponsiveness during allergen-induced airway
inflammation. Am J Pathol. 161:491–498. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Polte T, Behrendt AK and Hansen G: Direct
evidence for a critical role of CD30 in the development of allergic
asthma. J Allergy Clin Immunol. 118:942–948. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Albrecht M, Chen HC, Preston-Hurlburt P,
Ranney P, Hoymann HG, Maxeiner J, Staudt V, Taube C, Bottomly HK
and Dittrich AM: T(H)17 cells mediate pulmonary collateral priming.
J Allergy Clin Immunol. 128:168–177. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
38
|
Loke WS, Freeman A, Garthwaite L,
Prazakova S, Park M, Hsu K, Thomas PS and Herbert C: T-bet and
interleukin-27: Possible TH 1 immunomodulators of sarcoidosis.
Inflammopharmacology. 23:283–290. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kelly-Welch AE, Melo ME, Smith E, Ford AQ,
Haudenschild C, Noben-Trauth N and Keegan AD: Complex role of the
IL-4 receptor alpha in a murine model of airway inflammation:
Expression of the IL-4 receptor alpha on nonlymphoid cells of bone
marrow origin contributes to severity of inflammation. J Immunol.
172:4545–4555. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tang X, Nian H, Li X, Yang Y, Wang X, Xu
L, Shi H, Yang X and Liu R: Effects of the combined extracts of
Herba Epimedii and Fructus Ligustrilucidi on airway remodeling in
the asthmatic rats with the treatment of budesonide. BMC Complement
Altern Med. 17:3802017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Komai M, Tanaka H, Masuda T, Nagao K,
Ishizaki M, Sawada M and Nagai H: Role of Th2 responses in the
development of allergen-induced airway remodelling in a murine
model of allergic asthma. Br J Pharmacol. 138:912–920. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kohan M, Breuer R and Berkman N:
Osteopontin induces airway remodeling and lung fibroblast
activation in a murine model of asthma. Am J Respir Cell Mol Biol.
41:290–296. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Eifan AO, Orban NT, Jacobson MR and Durham
SR: Severe persistent allergic rhinitis. Inflammation but no
histologic features of structural upper airway remodeling. Am J
Respir Crit Care Med. 192:1431–1439. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Iwasaki Y, Fujio K, Okamura T and Yamamoto
K: Interleukin-27 in T cell immunity. Int J Mol Sci. 16:2851–2863.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ma N, Fang Y, Xu R, Zhai B, Hou C, Wang X,
Jiang Z, Wang L, Liu Q, Han G and Wang R: Ebi3 promotes T- and
B-cell division and differentiation via STAT3. Mol Immunol.
107:61–70. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hamid Q and Tulic M: Immunobiology of
asthma. Annu Rev Physiol. 71:489–507. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
O'Byrne PM and Inman MD: Airway
hyperresponsiveness. Chest. 123(3 Suppl): S411–S416. 2003.
View Article : Google Scholar
|
|
48
|
Kaczka DW, Ingenito EP, Israel E and
Lutchen KR: Airway and lung tissue mechanics in asthma. Effects of
albuterol. Am J Respir Crit Care Med. 159:169–178. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Tait Wojno ED, Hunter CA and Stumhofer JS:
The immunobiology of the interleukin-12 family: Room for discovery.
Immunity. 50:851–870. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Tumes DJ, Papadopoulos M, Endo Y, Onodera
A, Hirahara K and Nakayama T: Epigenetic regulation of T-helper
cell differentiation, memory, and plasticity in allergic asthma.
Immunol Rev. 278:8–19. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Jacobsen EA, Doyle AD, Colbert DC, Zellner
KR, Protheroe CA, LeSuer WE, Lee NA and Lee JJ: Differential
activation of airway eosinophils induces IL-13-mediated allergic
Th2 pulmonary responses in mice. Allergy. 70:1148–1159. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Pappu R, Ramirez-Carrozzi V and Sambandam
A: The interleukin-17 cytokine family: Critical players in host
defence and inflammatory diseases. Immunology. 134:8–16. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Vultaggio A, Nencini F, Pratesi S, Maggi
L, Guarna A, Annunziato F, Romagnani S, Parronchi P and Maggi E:
The TLR7 ligand 9-benzyl-2-butoxy-8-hydroxy adenine inhibits IL-17
response by eliciting IL-10 and IL-10-inducing cytokines. J
Immunol. 186:4707–4715. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Chesné J, Braza F, Mahay G, Brouard S,
Aronica M and Magnan A: IL-17 in severe asthma. Where do we stand?
Am J Respir Crit Care Med. 190:1094–1101. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Diveu C, McGeachy MJ, Boniface K,
Stumhofer JS, Sathe M, Joyce-Shaikh B, Chen Y, Tato CM, McClanahan
TK, de Waal Malefyt R, et al: IL-27 blocks RORc expression to
inhibit lineage commitment of Th17 cells. J Immunol. 182:5748–5756.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Muallem G, Wagage S, Sun Y, DeLong JH,
Valenzuela A, Christian DA, Harms Pritchard G, Fang Q, Buza EL,
Jain D, et al: IL-27 limits type 2 immunopathology following
Parainfluenza Virus infection. PLoS Pathog. 13:e10061732017.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Young A, Linehan E, Hams E, O'Hara Hall
AC, McClurg A, Johnston JA, Hunter CA, Fallon PG and Fitzgerald DC:
Cutting edge: Suppression of GM-CSF expression in murine and human
T cells by IL-27. J Immunol. 189:2079–2083. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Russell RJ and Brightling C: Pathogenesis
of asthma: Implications for precision medicine. Clin Sci (Lond).
131:1723–1735. 2017. View Article : Google Scholar
|
|
59
|
Tanabe T, Fujimoto K, Yasuo M, Tsushima K,
Yoshida K, Ise H and Yamaya M: Modulation of mucus production by
interleukin-13 receptor alpha2 in the human airway epithelium. Clin
Exp Allergy. 38:122–134. 2008. View Article : Google Scholar
|
|
60
|
Tanabe T and Rubin BK: Airway goblet cells
secrete Pro-inflammatory cytokines, chemokines, and growth factors.
Chest. 149:714–720. 2016. View Article : Google Scholar
|
|
61
|
Foster PS, Ming Y, Matthei KI, Young IG,
Temelkovski J and Kumar RK: Dissociation of inflammatory and
epithelial responses in a murine model of chronic asthma. Lab
Invest. 80:655–662. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Fernandes DJ, Bonacci JV and Stewart AG:
Extracellular matrix, integrins, and mesenchymal cell function in
the airways. Curr Drug Targets. 7:567–577. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Benayoun L, Druilhe A, Dombret MC, Aubier
M and Pretolani M: Airway structural alterations selectively
associated with severe asthma. Am J Respir Crit Care Med.
167:1360–1368. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Miller M, Cho JY, McElwain K, McElwain S,
Shim JY, Manni M, Baek JS and Broide DH: Corticosteroids prevent
myofibroblast accumulation and airway remodeling in mice. Am J
Physiol Lung Cell Mol Physiol. 290:L162–169. 2006. View Article : Google Scholar
|
|
65
|
Dong Z, Zhao X, Tai W, Lei W, Wang Y, Li Z
and Zhang T: IL-27 attenuates the TGF-β1-induced proliferation,
differentiation and collagen synthesis in lung fibroblasts. Life
Sci. 146:24–33. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Detoraki A, Granata F, Staibano S, Rossi
FW, Marone G and Genovese A: Angiogenesis and lymphangiogenesis in
bronchial asthma. Allergy. 65:946–958. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Hoshino M, Nakamura Y and Hamid QA: Gene
expression of vascular endothelial growth factor and its receptors
and angiogenesis in bronchial asthma. J Allergy Clin Immunol.
107:1034–1038. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Zhang Q, da Cunha AP, Li S, Hao Q, Kainz
V, Huang Q and Wu HY: IL-27 regulates HIF-1α-mediated VEGFA
response in macrophages of diabetic retinopathy patients and
healthy individuals. Cytokine. 113:238–247. 2019. View Article : Google Scholar
|
|
69
|
Di Carlo E, Sorrentino C, Zorzoli A, Di
Meo S, Tupone MG, Ognio E, Mincione G and Airoldi I: The antitumor
potential of Interleukin-27 in prostate cancer. Oncotarget.
5:10332–10341. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Kamiya S, Owaki T, Morishima N, Fukai F,
Mizuguchi J and Yoshimoto T: An indispensable role for STAT1 in
IL-27-induced T-bet expression but not proliferation of naive CD4+
T cells. J Immunol. 173:3871–3877. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Diegelmann J, Olszak T, Goke B, Blumberg
RS and Brand S: A novel role for interleukin-27 (IL-27) as mediator
of intestinal epithelial barrier protection mediated via
differential signal transducer and activator of transcription
(STAT) protein signaling and induction of antibacterial and
anti-inflammatory proteins. J Biol Chem. 287:286–298. 2012.
View Article : Google Scholar
|
|
72
|
Takeda A, Hamano S, Yamanaka A, Hanada T,
Ishibashi T, Mak TW, Yoshimura A and Yoshida H: Cutting edge: Role
of IL-27/WSX-1 signaling for induction of T-bet through activation
of STAT1 during initial Th1 commitment. J Immunol. 170:4886–4890.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Lucas S, Ghilardi N, Li J and de Sauvage
FJ: IL-27 regulates IL-12 responsiveness of naive CD4+ T cells
through Stat1-dependent and -independent mechanisms. Proc Natl Acad
Sci USA. 100:15047–15052. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Hwang ES, Szabo SJ, Schwartzberg PL and
Glimcher LH: T helper cell fate specified by kinase-mediated
interaction of T-bet with GATA-3. Science. 307:430–433. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Regis G, Pensa S, Boselli D, Novelli F and
Poli V: Ups and downs: The STAT1:STAT3 seesaw of Interferon and
gp130 receptor signalling. Semin Cell Dev Biol. 19:351–359. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Morandi F, Prigione I and Airoldi I: Human
TCRγδ+ T cells represent a novel target for IL-27 activity. Eur J
Immunol. 42:1547–1552. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Hwang ES: Transcriptional regulation of T
helper 17 cell differentiation. Yonsei Med J. 51:484–491. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Ivanov II, McKenzie BS, Zhou L, Tadokoro
CE, Lepelley A, Lafaille JJ, Cua DJ and Littman DR: The orphan
nuclear receptor RORgammat directs the differentiation program of
proinflammatory IL-17+ T helper cells. Cell.
126:1121–1133. 2006. View Article : Google Scholar : PubMed/NCBI
|
